Montalto, Giuseppe
Montalto, Giuseppe
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells
2016 Augello G.; Puleio R.; Emma M.R.; Cusimano A.; Loria G.R.; McCubrey J.A.; Montalto G.; Cervello M.
Abilities of ?-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
2020 Akula SM; Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Cocco L; Ramazzotti G; Ratti S; Follo MY; Martelli AM; Murata RM; Rosalen PL; BuenoSilva B; Matias de Alencar S; Falasca M; Montalto G; Melchiorre Cervello; Notarbartolo M; Gizak A; Rakus D; Libra M; McCubrey JA;
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
2019 Abrams S.L.; Follo M.Y.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ratti S.; Martelli A.M.; Candido S.; Libra M.; Murata R.M.; Rosalen P.L.; Montalto G.; Cervello M.; Gizak A.; Rakus D.; Mao W.; Lombardi P.; McCubrey J.A.
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells
2019 Akula, Sm; Candido, S; Libra, M; Abrams, Sl; Steelman, Ls; Lertpiriyapong, K; Ramazzotti, G; Ratti, S; Follo, My; Martelli, Am; Murata, Rm; Rosalen, Pl; Buenosilva, B; Matias de Alencar, S; Montalto, G; Cervello, M; Gizak, A; Rakus, D; Mao, W; Lin, Hl; Lombardi, P; Mccubrey, Ja
Altered gene expression profiles in liver cancer cells upon sorafenib treatment.
2010 Cervello, M; Bachvarov, D; Cusimano, A; Azzolina, A; Lampiasi, N; Abbaleo, S; Sardina, F; Giannitrapani, L; Mccubrey, Ja; Montalto, G
Altered gene expression profiles in liver cancer cells upon sorafenib treatment.
2011 Cervello, M; Cusimano, A; Bachvarov, D; Azzolina, A; Mccubrey, Ja; Montalto, G; Lampiasi, N
Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism.
2009 Lampiasi, N; Azzolina, A; D'Alessandro, N; Umezawa, K; Mccubrey, Ja; Montalto, G; Cervello, M
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells.
2005 Cusimano, A; Foderà, D; Lampiasi, N; Azzolina, A; Montalto, G; Cervello, M
Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells.
2008 Miceli, V; Cervello, M; Valenti, F; Montalto, G; Calabrò, M; Carruba, G
Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells.
2008 Miceli, V; Cervello, M; Valenti, F; Montalto, G; Calabrò, M; Carruba, G
Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells.
2009 Miceli V; Cervello M; Azzolina A; Montalto G; Calabrò M; Carruba G.
Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample
2018 Augello, Giuseppa; Balasus, Daniele; Fusilli, Caterina; Mazza, Tommaso; Emma, MARIA RITA; Giannitrapani, Lydia; Agliastro, Rosalia; Cervello, Melchiorre; Montalto, Giuseppe
Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-±, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma.
2011 Giacalone A; Montalto G; Giannitrapani L; Balasus D; Terranova A; Cervello M; Soresi M; Marasà L.
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study
2016 Toth, Peter P.; Toth, Peter P.; Toth, Peter P.; Patti, Angelo M.; Patti, Angelo M.; Nikolic, Dragana; Giglio, Rosaria V.; Giglio, Rosaria V.; Castellino, Giuseppa; Biancucci, Teresa; Geraci, Fabiana; Geraci, Fabiana; David, Sabrina; Montalto, Giuseppe; Montalto, Giuseppe; Rizvi, Ali; Rizzo, Manfredi; Rizzo, Manfredi; Rizzo, Manfredi
Cancer therapy and treatments during COVID-19 era
2020 Makula, Shaw; L Abrams, Stephen; Ssteelman, Linda; Saveriocandido, ; Massimolibra, ; Kvinlerpiriyapong, ; Luciococco, ; Giuliaramazzotti, ; Ratti, Stefano; Yfollo, Matilde; Mmartelli, Alberto; L Blalock, William; Piazzi, Manuela; Montalto, Giuseppe; Cervello, Melchiorre; Notarbartolo, Monica; Basecke, Jorg; A McCubrey, James
Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment.
2001 Montalto, G; Giannitrapani, L; Soresi, M; Virruso, L; Martino, Dd; Gambino, R; Carroccio, A; Cervello, M
Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells.
2011 Lampiasi, N; Azzolina, A; Umezawa, K; Mccubrey, Ja; Montalto, G; Cervello, M
Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response.
2008 Cusimano, A; Iovanna, Jl; Dalessandro, N; Azzolina, A; Montalto, G; Cervello, M
Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response.
2008 Cusimano, A; Iovanna, Jl; Dalessandro, N; Azzolina, A; Montalto, G; Cervello, M
Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells
2007 Lampiasi N; DAlessandro N; Umezawa K; Azzolina A; Montalto G; Cervello M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells | 1-gen-2016 | Augello G.; Puleio R.; Emma M.R.; Cusimano A.; Loria G.R.; McCubrey J.A.; Montalto G.; Cervello M. | |
| Abilities of ?-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells | 1-gen-2020 | Akula SM; Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Cocco L; Ramazzotti G; Ratti S; Follo MY; Martelli AM; Murata RM; Rosalen PL; BuenoSilva B; Matias de Alencar S; Falasca M; Montalto G; Melchiorre Cervello; Notarbartolo M; Gizak A; Rakus D; Libra M; McCubrey JA; | |
| Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells | 1-gen-2019 | Abrams S.L.; Follo M.Y.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ratti S.; Martelli A.M.; Candido S.; Libra M.; Murata R.M.; Rosalen P.L.; Montalto G.; Cervello M.; Gizak A.; Rakus D.; Mao W.; Lombardi P.; McCubrey J.A. | |
| Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells | 1-gen-2019 | Akula, Sm; Candido, S; Libra, M; Abrams, Sl; Steelman, Ls; Lertpiriyapong, K; Ramazzotti, G; Ratti, S; Follo, My; Martelli, Am; Murata, Rm; Rosalen, Pl; Buenosilva, B; Matias de Alencar, S; Montalto, G; Cervello, M; Gizak, A; Rakus, D; Mao, W; Lin, Hl; Lombardi, P; Mccubrey, Ja | |
| Altered gene expression profiles in liver cancer cells upon sorafenib treatment. | 1-gen-2010 | Cervello, M; Bachvarov, D; Cusimano, A; Azzolina, A; Lampiasi, N; Abbaleo, S; Sardina, F; Giannitrapani, L; Mccubrey, Ja; Montalto, G | |
| Altered gene expression profiles in liver cancer cells upon sorafenib treatment. | 1-gen-2011 | Cervello, M; Cusimano, A; Bachvarov, D; Azzolina, A; Mccubrey, Ja; Montalto, G; Lampiasi, N | |
| Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. | 1-gen-2009 | Lampiasi, N; Azzolina, A; D'Alessandro, N; Umezawa, K; Mccubrey, Ja; Montalto, G; Cervello, M | |
| Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. | 1-gen-2005 | Cusimano, A; Foderà, D; Lampiasi, N; Azzolina, A; Montalto, G; Cervello, M | |
| Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells. | 1-gen-2008 | Miceli, V; Cervello, M; Valenti, F; Montalto, G; Calabrò, M; Carruba, G | |
| Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells. | 1-gen-2008 | Miceli, V; Cervello, M; Valenti, F; Montalto, G; Calabrò, M; Carruba, G | |
| Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. | 1-gen-2009 | Miceli V; Cervello M; Azzolina A; Montalto G; Calabrò M; Carruba G. | |
| Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample | 1-gen-2018 | Augello, Giuseppa; Balasus, Daniele; Fusilli, Caterina; Mazza, Tommaso; Emma, MARIA RITA; Giannitrapani, Lydia; Agliastro, Rosalia; Cervello, Melchiorre; Montalto, Giuseppe | |
| Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-±, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma. | 1-gen-2011 | Giacalone A; Montalto G; Giannitrapani L; Balasus D; Terranova A; Cervello M; Soresi M; Marasà L. | |
| Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study | 1-gen-2016 | Toth, Peter P.; Toth, Peter P.; Toth, Peter P.; Patti, Angelo M.; Patti, Angelo M.; Nikolic, Dragana; Giglio, Rosaria V.; Giglio, Rosaria V.; Castellino, Giuseppa; Biancucci, Teresa; Geraci, Fabiana; Geraci, Fabiana; David, Sabrina; Montalto, Giuseppe; Montalto, Giuseppe; Rizvi, Ali; Rizzo, Manfredi; Rizzo, Manfredi; Rizzo, Manfredi | |
| Cancer therapy and treatments during COVID-19 era | 1-gen-2020 | Makula, Shaw; L Abrams, Stephen; Ssteelman, Linda; Saveriocandido, ; Massimolibra, ; Kvinlerpiriyapong, ; Luciococco, ; Giuliaramazzotti, ; Ratti, Stefano; Yfollo, Matilde; Mmartelli, Alberto; L Blalock, William; Piazzi, Manuela; Montalto, Giuseppe; Cervello, Melchiorre; Notarbartolo, Monica; Basecke, Jorg; A McCubrey, James | |
| Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment. | 1-gen-2001 | Montalto, G; Giannitrapani, L; Soresi, M; Virruso, L; Martino, Dd; Gambino, R; Carroccio, A; Cervello, M | |
| Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells. | 1-gen-2011 | Lampiasi, N; Azzolina, A; Umezawa, K; Mccubrey, Ja; Montalto, G; Cervello, M | |
| Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. | 1-gen-2008 | Cusimano, A; Iovanna, Jl; Dalessandro, N; Azzolina, A; Montalto, G; Cervello, M | |
| Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. | 1-gen-2008 | Cusimano, A; Iovanna, Jl; Dalessandro, N; Azzolina, A; Montalto, G; Cervello, M | |
| Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells | 1-gen-2007 | Lampiasi N; DAlessandro N; Umezawa K; Azzolina A; Montalto G; Cervello M |